Impact of Body Weight on Pharmacokinetic Analysis of Doxorubicin + Cyclophosphamide in Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01542203
Recruitment Status : Withdrawn (study is classified as ancillary / correlative)
First Posted : March 2, 2012
Last Update Posted : June 5, 2018
Texas Tech University Health Sciences Center
Information provided by (Responsible Party):
University of Texas Southwestern Medical Center

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Actual Primary Completion Date : September 15, 2016
  Actual Study Completion Date : June 5, 2017